<div id="readability-page-1"><p><span>Corteva (NYSE:CTVA - Get Free Report)</span> was downgraded by equities research analysts at Wall Street Zen from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report issued on Wednesday.</p><ul><li>These 3 Stocks Just Got Upgraded—and Could Keep Climbing</li></ul><p>CTVA has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Corteva from $90.00 to $85.00 and set a &#34;buy&#34; rating for the company in a research note on Thursday, November 6th. JPMorgan Chase &amp; Co. raised shares of Corteva from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and set a $67.00 price target on the stock in a report on Thursday, October 2nd. Wolfe Research increased their price objective on Corteva from $79.00 to $80.00 and gave the company an &#34;outperform&#34; rating in a report on Thursday, November 6th. Wells Fargo &amp; Company lowered their price objective on Corteva from $80.00 to $77.00 and set an &#34;overweight&#34; rating for the company in a research report on Tuesday, November 11th. Finally, The Goldman Sachs Group reduced their target price on Corteva from $85.00 to $77.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, October 22nd. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued  a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $78.05.</p><p><b>Check Out Our Latest Research Report on Corteva</b></p><h2>Corteva Trading Up 1.2%</h2><ul><li>How Trump’s AI Push Could Boost These 3 Agriculture Stocks</li></ul><p>Shares of NYSE CTVA opened at $65.85 on Wednesday. Corteva has a 1-year low of $53.40 and a 1-year high of $77.41. The business has a fifty day moving average price of $64.09 and a 200 day moving average price of $69.55. The stock has a market capitalization of $44.50 billion, a P/E ratio of 28.14, a price-to-earnings-growth ratio of 1.48 and a beta of 0.74. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07. </p><p>Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.49) by $0.26. The company had revenue of $2.62 billion for the quarter, compared to analyst estimates of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The firm's quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.49) earnings per share.  Equities research analysts expect that  Corteva will post 2.96 EPS for the current fiscal year. </p><h2>Hedge Funds Weigh In On Corteva</h2><ul><li>2 Agriculture Stocks To Benefit From a Trump Presidency in 2025 </li></ul><p>A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in  Corteva by 0.5% during the second quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company's stock worth $5,976,436,000 after acquiring an additional 373,680 shares during the period.  State Street Corp boosted its position in  Corteva by 3.6% in the 3rd quarter. State Street Corp now owns 35,280,805 shares of the company's stock worth $2,386,041,000 after purchasing an additional 1,230,074 shares in the last quarter.  Franklin Resources Inc. grew its stake in shares of  Corteva by 5.9% during the 3rd quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company's stock worth $1,266,820,000 after purchasing an additional 1,051,389 shares during the period.  Geode Capital Management LLC increased its holdings in shares of  Corteva by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company's stock valued at $1,339,651,000 after purchasing an additional 251,693 shares in the last quarter.  Finally, Independent Franchise Partners LLP lifted its stake in shares of  Corteva by 1.8% in the 1st quarter. Independent Franchise Partners LLP now owns 16,785,300 shares of the company's stock valued at $1,056,299,000 after purchasing an additional 288,792 shares during the period. Hedge funds and other institutional investors own  81.54% of the company's stock. </p><h2>About Corteva</h2> (Get Free Report)<p>Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.</p><h2>See Also</h2><ul><li>Five stocks we like better than Corteva</li><li>What Are Growth Stocks and Investing in Them </li><li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li><li>What is Forex and How Does it Work? </li><li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li><li>Stock Dividend Cuts Happen Are You Ready?</li><li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNUVkE?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNUVkE"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Corteva Right Now?</h2><p>Before you consider Corteva, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.</p><p>While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CTVA

<p>Wall Street Zen downgraded Corteva (NYSE:CTVA) from a "buy" to "hold" rating. Other analysts have varied opinions, with Deutsche Bank lowering its price target, while JPMorgan and Wolfe Research upgraded their ratings. Corteva's stock opened at $65.85, with a market cap of $44.50 billion. The company reported better-than-expected earnings, with revenue up 6.5% year-over-year. Institutional investors hold 81.54% of the stock.</p>

Corteva (NYSE:CTVA) Downgraded to "Hold" Rating by Wall Street Zen